Characterization of a Novel Fusion Protein from IpaB and IpaD of Shigella spp. and Its Potential as a Pan-Shigella Vaccine

Shigellosis is an important disease in the developing world, where about 90 million people become infected with Shigella spp. each year. We previously demonstrated that the type three secretion apparatus (T3SA) proteins IpaB and IpaD are protective antigens in the mouse lethal pulmonary model. In or...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Martinez-Becerra, Francisco J., Chen, Xiaotong, Dickenson, Nicholas E., Choudhari, Shyamal P., Harrison, Kelly, Clements, John D., Picking, William D., Van De Verg, Lillian L., Walker, Richard I., Picking, Wendy L.
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 2013
Assuntos:
Microbial Immunity and Vaccines
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3837967/
https://ncbi.nlm.nih.gov/pubmed/24060976
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/IAI.00859-13
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares